Related Experiment Videos
Cryptococcal meningitis in the acquired immunodeficiency syndrome.
1Department of Medicine, University of California, San Francisco 94102.
Seminars in Respiratory Infections
|June 1, 1990
Summary
Cryptococcal meningitis, a common fungal infection in AIDS patients, presents subtly and is difficult to diagnose with routine tests. Newer antifungal therapies like oral fluconazole offer effective outpatient treatment and improve survival rates.
Area of Science:
- Infectious Diseases
- Mycology
- Immunocompromised Host Infections
Background:
- Cryptococcosis is a significant opportunistic infection in individuals with Acquired Immunodeficiency Syndrome (AIDS).
- Cryptococcal meningitis is the most prevalent clinical manifestation, often presenting with subtle symptoms and non-specific physical findings.
- Standard laboratory diagnostics frequently yield inconclusive results for cryptococcal meningitis in AIDS patients.
Purpose of the Study:
- To review the diagnostic challenges and evolving therapeutic strategies for cryptococcal meningitis in the context of AIDS.
- To highlight the utility of cryptococcal antigen testing and the role of cerebrospinal fluid cultures in diagnosis.
- To discuss current and emerging antifungal treatment options, emphasizing outpatient management and long-term outcomes.
Main Methods:
- Review of current literature on cryptococcosis and cryptococcal meningitis in AIDS patients.
- Analysis of diagnostic methods, including cerebrospinal fluid (CSF) analysis and antigen detection.
- Evaluation of antifungal therapies, including Amphotericin B, flucytosine, and fluconazole.
Main Results:
- Cryptococcal meningitis in AIDS patients often has an indolent course with non-specific clinical and laboratory findings.
- Serum and CSF cryptococcal antigen (CRAG) tests are sensitive diagnostic markers, while CSF culture remains the gold standard.
- Amphotericin B is a primary treatment, but oral fluconazole shows promise for both initial and maintenance therapy, potentially improving survival and reducing relapse rates.
Conclusions:
- Effective diagnosis of cryptococcal meningitis in AIDS relies on antigen testing and CSF culture, overcoming limitations of routine tests.
- Antifungal therapy is shifting towards outpatient-friendly options, with fluconazole emerging as a key agent for maintenance therapy.
- Optimized antifungal strategies, including maintenance therapy, are crucial for reducing relapse and improving survival in AIDS patients with cryptococcal meningitis.